Cargando…

Acvr1 deletion in osteoblasts impaired mandibular bone mass through compromised osteoblast differentiation and enhanced sRANKL‐induced osteoclastogenesis

Bone morphogenetic protein (BMP) signaling is well known in bone homeostasis. However, the physiological effects of BMP signaling on mandibles are largely unknown, as the mandible has distinct functions and characteristics from other bones. In this study, we investigated the roles of BMP signaling i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yue, Hao, Xinqing, Liu, Cangwei, Ren, Chunxia, Wang, Shuangshuang, Yan, Guangxing, Meng, Yuan, Mishina, Yuji, Shi, Ce, Sun, Hongchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048423/ https://www.ncbi.nlm.nih.gov/pubmed/33251612 http://dx.doi.org/10.1002/jcp.30183

Ejemplares similares

Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK
por: Evans, CE, et al.
Publicado: (2006)

Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors
por: Shi, Ce, et al.
Publicado: (2016)

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
por: Lee, Do-Won, et al.
Publicado: (2018)

Melatonin inhibits osteoclastogenesis via RANKL/OPG suppression mediated by Rev‐Erbα in osteoblasts
por: Tian, Yihao, et al.
Publicado: (2022)

A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
por: Murakami, Kohei, et al.
Publicado: (2017)

Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional Study
por: Nava-Valdivia, C. A., et al.
Publicado: (2021)

Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis
por: Kurz, Katharina, et al.
Publicado: (2015)

Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL
por: Kassem, Ali, et al.
Publicado: (2016)

Decreased level of soluble receptor activator of nuclear factor-κβ ligand (sRANKL) in overweight and obese children
por: Erazmus, Michał, et al.
Publicado: (2022)

BMP-induced Atoh8 attenuates osteoclastogenesis by suppressing Runx2 transcriptional activity and reducing the Rankl/Opg expression ratio in osteoblasts
por: Yahiro, Yuhei, et al.
Publicado: (2020)

Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation
por: El-Desoky, Ahmed H. H., et al.
Publicado: (2022)

RANKL-RANK signaling regulates osteoblast differentiation and bone formation
por: Cao, Xu
Publicado: (2018)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
por: Jansen, Ineke D.C., et al.
Publicado: (2020)

Chondrocyte‐to‐osteoblast transformation in mandibular fracture repair
por: Wong, Sarah A., et al.
Publicado: (2020)

Roles of matricellular CCN2 deposited by osteocytes in osteoclastogenesis and osteoblast differentiation
por: Nishida, Takashi, et al.
Publicado: (2019)

‘Educated’ Osteoblasts Reduce Osteoclastogenesis in a Bone-Tumor Mimetic Microenvironment
por: Kolb, Alexus D., et al.
Publicado: (2021)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

Petunidin, a B-ring 5′-O-Methylated Derivative of Delphinidin, Stimulates Osteoblastogenesis and Reduces sRANKL-Induced Bone Loss
por: Nagaoka, Masahiro, et al.
Publicado: (2019)

miR-208a-3p Suppresses Osteoblast Differentiation and Inhibits Bone Formation by Targeting ACVR1
por: Arfat, Yasir, et al.
Publicado: (2017)

GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation
por: Liu, Weiqing, et al.
Publicado: (2016)

The Effect of Osteoblast Isolation Methods from Adult Rats on Osteoclastogenesis in Co-Cultures
por: Žižková, Radmila, et al.
Publicado: (2022)

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
por: Zhang, Shiqian, et al.
Publicado: (2017)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression.
por: Narimiya, Tsuyoshi, et al.
Publicado: (2019)

Peonidin-3-O-glucoside and Resveratrol Increase the Viability of Cultured Human hFOB Osteoblasts and Alter the Expression of Genes Associated with Apoptosis, Osteoblast Differentiation and Osteoclastogenesis
por: Ostos Mendoza, Keila C., et al.
Publicado: (2023)

RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
por: Kukita, Toshio, et al.
Publicado: (2004)

TRPM7 Is Essential for RANKL-Induced Osteoclastogenesis
por: Yang, Yu-Mi, et al.
Publicado: (2013)

RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
por: Sung, Bokyung, et al.
Publicado: (2013)

Chitosan-Collagen 3D Matrix Mimics Trabecular Bone and Regulates RANKL-Mediated Paracrine Cues of Differentiated Osteoblast and Mesenchymal Stem Cells for Bone Marrow Macrophage-Derived Osteoclastogenesis
por: Elango, Jeevithan, et al.
Publicado: (2019)

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling
por: Wang, Xueying, et al.
Publicado: (2006)

Osteoclast-Derived Extracellular Vesicles: Novel Regulators of Osteoclastogenesis and Osteoclast–Osteoblasts Communication in Bone Remodeling
por: Yuan, Feng-Lai, et al.
Publicado: (2018)

Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization
por: Shim, Ki-Shuk, et al.
Publicado: (2017)

RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells
por: Yuan, Ling-Qing, et al.
Publicado: (2011)

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
por: Xiong, Jinhu, et al.
Publicado: (2015)

RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
por: Chen, Xiao, et al.
Publicado: (2018)

Deficiency of osteoblastic Arl6ip5 impaired osteoblast differentiation and enhanced osteoclastogenesis via disturbance of ER calcium homeostasis and induction of ER stress-mediated apoptosis
por: Wu, Y, et al.
Publicado: (2014)

Effect of Osteoblast‐Specific Deletion of the Proton Receptor OGR1
por: Krieger, Nancy S, et al.
Publicado: (2022)

BMP signaling in the development and regeneration of tooth roots: from mechanisms to applications
por: Liu, Cangwei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h5ppjbgmuvaf0lea4v0c67pfph